Glucose Monitoring and Antipsychotic Medication An Audit by Dr Emma Kelson - PowerPoint PPT Presentation

1 / 13
About This Presentation
Title:

Glucose Monitoring and Antipsychotic Medication An Audit by Dr Emma Kelson

Description:

Just over a third of patients had blood glucose checked in last year. Whose responsibility is it to request bloods, make sure patients have the tests ... – PowerPoint PPT presentation

Number of Views:184
Avg rating:3.0/5.0
Slides: 14
Provided by: alder8
Category:

less

Transcript and Presenter's Notes

Title: Glucose Monitoring and Antipsychotic Medication An Audit by Dr Emma Kelson


1
Glucose Monitoring and Antipsychotic Medication
An Audit by Dr Emma Kelson
  • Presented by Dr Yas Daudjee

2
Background
  • Research suggests antipsychotics increase blood
    glucose
  • Possibly more so by the atypicals
  • Elevated blood glucose may be a marker for future
    impaired glucose tolerance, insulin resistance,
    Type 2 diabetes and the metabolic syndrome

3
Aims
  • Do we meet AWP standards for blood glucose
    monitoring in patients on antipsychotics?
  • AWP standard baseline blood glucose check prior
    to prescribing any antipsychotic, and subsequent
    annual check

4
Method
  • Bristol Central CLDT database used to identify
    all patients on antipsychotics and their
    diagnosis. This information was confirmed by case
    note review
  • Records reviewed by hand was blood glucose
    requested in the last year, and was the result
    documented?
  • If not, GP surgeries were phoned up to see if the
    blood test had been done

5
Results
  • 62 patients identified
  • 42 on atypicals
  • Risperidone 18 oral, 1 IM
  • Olanzapine 11
  • Amisulpiride 4
  • Quetiapine 3
  • Aripiprazole - 3
  • Clozapine 2
  • 20 on typicals
  • Zuclopenthixol 6 oral, 3 IM
  • Sulpiride 4
  • Benperidol 3
  • Chlorpromazine - 2
  • Trifluperazine 1
  • Haloperidol 1

6
Results continued
  • 30 patients had blood tests in last year
  • 22 patients had random blood glucose checked in
    last year (73 of those who had blood tests,
    35 of all patients on antipsychotics) all
    normal
  • 15 out of the 42 on atypicals (68 of those who
    had blood glucose checked, 36 of all patients
    on atypical antipsychotics)
  • 6 out of the 20 on typicals (30 of all patients
    on typicals)
  • 15 requested by psychiatry (68), 6 requested by
    GP, 1 unknown (probably GP)
  • 4 patients had blood glucose requested, but not
    done
  • Unable to determine if baseline checked (most on
    antipsychotics gt 7 years)
  • 3 of the 22 were inpatients, with blood glucose
    checked as an inpatient
  • Only 7 documented in the medical notes prior to
    audit (32)

7
FLOWCHART OF RESULTS
15
22
6
30
62
8
32
HAD BLOODS
TOTAL
HAD GLUCOSE
ATYPICAL/TYPICAL
8
Discussion
  • Good practice
  • Inpatient bloods checked during admission
  • 2/3 of atypicals are being checked
  • Discussion points
  • Just over a third of patients had blood glucose
    checked in last year
  • Whose responsibility is it to request bloods,
    make sure patients have the tests and chase
    results us, GP or carers/patients? Would we get
    better results if we filled out blood forms
    ourselves (with copies of tests to GPs) rather
    than asking for tests in our clinic letters
    (sometimes repeatedly)? What does the legal
    responsibility lie does the doctor who asks for
    the blood test have a duty to follow it up and
    act on the result?
  • No gold standard for monitoring, but AWP have
    guidance as do Maudsley. There are significant
    difference between them though. Does BANES have a
    policy which we should be following currently?
  • Different GP surgeries have different systems of
    monitoring. Are there shared care protocols
    operating?
  • Is the one page AWP summary of required tests
    disseminated to GPs?
  • What is the role of pharmacists?

9
Comparison to National Audit
  • The Prescribing Observatory for Mental Health
    (POMH) is a national quality improvement
    programme open to all specialist mental health
    services, based at the RCPsychs Centre for
    Quality Improvement. Their aim is to help mental
    health services monitor and maintain or improve
    the quality of their mental health prescribing
    practice.
  • What does POMH do? - Identifies Topics within
    mental health prescribing that warrant attention,
    and develops for each a programme of clinical
    audit and quality improvement to help services
    improve in that area
  • Current Topics
  • Rx of high-dose and combination antipsychotics on
    adult acute PICU wards
  • Screening for metabolic side effects of
    antipsychotics among assertive outreach team
    patients
  • Rx of high-dose and combination antipsychotics on
    forensic wards
  • Benchmarking the Rx of anti-dementia drugs (from
    June 2007)
  • Benchmarking the Rx high-dose and combination
    antipsychotics on adult acute PICU wards
    (extension of Topic 1)
  • Assessment and monitoring of side effects of
    psychotropic medication (in development)

10
UK Audit
  • Minimum audit standard all patients should have
    BP, BMI (or other measurement of obesity such as
    waist circumference), blood glucose (or HbA1c)
    and plasma lipids yearly
  • Audit of 1966 patients of 48 AO teams (21 mental
    health trusts)
  • BP 26, obesity 17, blood glucose (or HbA1c)
    28, plasma lipids 22
  • All 4 measurements documented in 11
  • Range of morbidity 6 diabetes (50 of
    expected), 6 hypertension (20 of expected), 6
    dyslipidaemia (13 expected)
  • Questionnaire of obstacles uncertainty about
    responsibility, lack of confidence about
    interpretation of abnormal results, limited
    access to basic equipment

11
Re-Audit Comparison (2004 and 2007)
  • Number of patients on antipsychotics 82 (in
    2004), 62 (in 2007)
  • of patient population on antipsychotic drugs
    49 in 2004, 45 in 2007
  • Number of patients prescribed drugs within BNF
    dosage 100 in both audits (Compared with POMH
    data only 36 with BNF dosage)
  • Number of patients prescribed within licenceoff
    licence
  • 2004 5530
  • 2007 4852
  • Off licence number of prescriptions increased
    slightly (26 up to 35), but very different
    indications between the two audits, for example
    2004 indication of autism changed in 2007 to
    Generalised Anxiety Disorder
  • Depot 9 (in 2004), 5 (in 2007)
  • Patients without psychiatric diagnosis, but with
    challenging behaviour 10 in 2004 (12), 9 in
    2007 (15)
  • Patients without any diagnosis 8 in 2004
    (10), 5 in 2007 (8)
  • Number of patients on atypicalstypicals
  • 2004 6337
  • 2007 6832
  • Risperidone - 63 in 2004, 45 in 2007

12
Suggested Recommendations
  • Psychiatrists to routinely ask for blood glucose
    on initiation of antipsychotics, and annually
    thereafter
  • Psychiatrists to remember to ask for blood
    glucose in letters when requesting blood tests
    from GPs
  • Psychiatrists to chase up blood tests when
    results are not forwarded on to us
  • Clinical Governance Lead to consider the issue of
    shared care protocols for physical healthcare
    monitoring for patients on antipsychotic
    medication

13
Agreed Recommendations
  • Psychiatrists to routinely ask for blood glucose
    test on initiation of antipsychotics, and
    annually thereafter
  • Agreed at academic meeting by medical staff on
    14/11/07
Write a Comment
User Comments (0)
About PowerShow.com